BREAKING NEWS

网页链接{Novartis will change CRO relationships ‘over time’ as Senate bill targeting Chinese companies looms}

Novartis is “actively” managing its existing relationships with Chinese service providers to mitigate risks if the Biosecure Act passes. CFO Harry Kirsch told media on Tuesday morning Novartis currently has “a little bit of connections” to Chinese providers such as CROs, although he did not specify which ones.